Signal Transduction Pathways, Part A: Apoptotic and Extracellular Signaling, Volume 1090

Novel antibodies against receptors, protein kinase inhibitors, and antisense oligonucleotides targeting both signal transduction and gene expression will predominate the therapeutic approaches in the coming decades.
This volume is part of a series of meetings held in Luxembourg to discuss therapeutic applications in the field of signal transduction, transcription, and translation. These meetings and the volumes comprising their proceedings have brought forward new insights in this rapidly moving field.
Chapters on hypoxia signal transduction, phosphoserine/threonine–binding domains, targeting of polycomb repressive complexes, conserved signaling mechanisms in innate immunity, and signal transduction by stress–activated MAP kinases have been provided by the keynote speakers at the meeting. Other topics included among these reports on recent research are receptor signaling, protein kinase cascades as therapeutic targets, cell death in cancer, inflammation–specific signaling, cell signaling pathways leading to regulated chromatin modifications, and transcriptional control.
Part A focuses on basic research, and the chapters are divided into the following sections: apoptotic cell signaling mechanisms, extracellular matrix interactions, and MAP kinases.
NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit www.blackwellpublishing.com/nyas.
ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Science receive full–text access to the Annals online and discounts on print volumes. Please visit www.nyas.org/membership/main.asp for more information about becoming a member.

Spis treści:
Part I: Apoptotic Cell Signaling Mechanisms:.
1. Pleiotropic Effects of PI–3’ Kinase/Akt Signaling in Human Hepatoma Cell Pr oliferation and Drug–Induced Apoptosis: Catherine Alexia, Marl`Ene Bras, Guillaume Fallot, Nathalie Vadrot, Fanny Daniel, Malika Lasfer, Houda Tamouza, and Andre Groyer.
2. Expression of Bcl–xL, Bax, and p53 in Primary Tumors and Lymph Node Metastases in Oral Squamous Cell Carcinoma: Marek Baltaziak, Ewa Duraj, Mariusz Koda, Andrzej Wincewicz, Marcin Musiatowicz, Luiza Kanczuga–Koda, Magdalena Szymanska, Tomasz Lesniewicz, and Boguslaw Musiatowicz.
3. Reactive Structural Dynamics of Synaptic Mitochondria in Ischemic Delayed Neuronal Death: Carlo Bertoni–Freddari, Patrizia Fattoretti, Tiziana Casoli, Giuseppina Di Stefano, Moreno Solazzi, Elisa Perna, and Clara De Angelis.
4. Selective Resistance of Tetraploid Cancer Cells against DNA Damage–Induced Apoptosis: Maria Castedo, Arnaud Coquelle, Ilio Vitale, Sonia Vivet, Shahul Mouhamad, Sophie Viaud, Laurence Zitvogel, and Guido Kroemer.
5. Molecular Determinants Involved in the Increase of Damage–Induced Apoptosis and Delay of Secondary Necrosis due to Inhibition of Mono(ADP–Ribosyl)ation: Claudia Cerella, Cristina Mearelli, Sergio Ammendola, Milena De Nicola, Maria D’alessio, Andrea Magrini, Antonio Bergamaschi, and Lina Ghibelli.
6. Magnetic Fields Protect from Apoptosis via Redox Alteration: M. De Nicola, S. Cordisco, C. Cerella, M.C. Albertini, M. D’alessio, A. Accorsi, A. Bergamaschi, A. Magrini, and L. Ghibelli.
7. The Cleavage Mode of Apoptotic Nuclear Vesiculation Is Related to Plasma Membrane Blebbing and Depends on Actin Reorganization: M. De Nicola, C. Cerella, M. D’alessio, S. Coppola, A. Magrini, A. Bergamaschi, and L. Ghibelli.
8. Experimental Apoptosis Provides Clues about the Role of Mitochondrial Changes in Neuronal Death: Patrizia Fattoretti, Carlo Bertoni–Freddari, Rina Recchioni, Belinda Giorgetti, Marta Balietti, Yessica Grossi, Moreno Solazzi, Tiziana Casoli, Giuseppina Di Stefano, and Fiorella Marcheselli.
9. Alterations in mRNA Expression of Apoptosis–Related Genes BCL2, BAX, FAS, Caspase–3, and the Novel Member BCL2L12 after Treatment of Human Leukemic Cell Line HL60 with the Antineoplastic Agent Etoposide: Kostas V. Floros, Hellinida Thomadaki, Dimitra Florou, Maroulio Talieri, and Andreas Scorilas.
10. Using Janus Green B to Study Paraquat Toxicity in Rat Liver Mitochondria: Role of ACE Inhibitors (Thiol and Nonthiol ACEi): M. Ghazi–Khansari, A. Mohammadi–Bardbori, and M–J. Hosseini.
11. Membrane Fluidity Changes Are Associated with Benzo[a]Pyrene–Induced Apoptosis in F258 Cells: Protection by Exogenous Cholesterol: Morgane Gorria, Xavier Tekpli, Odile Sergent, Laurence Huc, Francois Gaboriau, Mary Rissel, Martine Chevanne, Marie–Therese Dimanche–Boitrel, and Dominique Lagadic–Gossmann.
12. Metal–Containing Proteins in the Apoptosis and Redox Processes in the Rat Prostate and Human Prostate Cells: I. Grbavac, C. Wolf, N. Wenda, D. Alber, M. Kuhbacher, D. Behne, and A. Kyriakopoulos.
13. Does Transduced p27 Induce Apoptosis in Human Tumor Cell Lines?: Mira Grdisa, Ana–Matea Mikecin, and Miroslav Poznic.
14. Apoptotic Cell Signaling in Lymphocytes from HIV+ Patients during Successful Therapy: Sandro Grelli, Emanuela Balestrieri, Claudia Matteucci, Antonella Minutolo, Gabriella D’ettorre, Filippo Lauria, Francesco Montella, Vincenzo Vullo, Stefano Vella, Cartesio Favalli, Antonio Mastino, and Beatrice Macchi.
15. Capacitation and Acrosome Reaction in Nonapoptotic Human Spermatozoa: Sonja Grunewald, Thomas Baumann, Uwe Paasch, and Hans–Juergen Glander.
16. Caspase Activation and Extracellular Signal–Regulated Kinase/Akt Inhibition Were Involved in Luteolin–Induced Apoptosis in Lewis Lung Carcinoma Cells: Jin–Hyung Kim, Eun–Ok Lee, Hyo–Jung Lee, Jin–Sook Ku, Min–Ho Lee, Deok–Chun Yang, and Sung–Hoon Kim.
17. Cerami de Modulation of Antigen–Triggered Ca2+ Signals and Cell Fate: Diversity in the Responses of Various Immunocytes: Endre Kiss, Gabriella Sarmay, and Janos Matko.
18. Caspase–3 Activation, Bcl–2 Contents, and Soluble FAS–Ligand Are Not Related to the Inflammatory Marker Profile in Patients with Sepsis and Septic Shock: Fabian Kriebel, Silke Wittemann, Hsin–Yun Hsu, Thomas Joos, Manfred Weiss, and E. Marion Schneider.
19. Two Forms of the Nuclear Matrix–Bound p53 Protein in HEK293 Cells: Maria A. Lapshina, Igor I. Parkhomenko, and Alexei A. Terentiev.
20. Jpk, a Novel Cell Death Inducer, Regulates the Expression of Hoxa7 in F9 Teratocarcinoma Cells, but not during Apoptosis: Eun Young Lee and Myoung Hee Kim.
21. HGF/SF Regulates Expression of Apoptotic Genes in MCF–10A Human Mammary Epithelial Cells: Catherine Leroy, Julien Deheuninck, Sylvie Reveneau, Benedicte Foveau, Zongling Ji, Celine Villenet, Sabine Quief, David Tulasne, Jean–Pierre Kerckaert, and Veronique Fafeur.
22. Arsenic Trioxide Represses NF–kB Activation and Increases Apoptosis in ATRA–Treated APL Cells: Julie Mathieu and Francoise Besancon.
23. Cytotoxicity of TRAIL/Anticancer Drug Combinations in Human Normal Cells: Olivier Meurette, Anne Fontaine, Amelie Rebillard, Gwenaelle Le Moigne, Thierry Lamy, Dominique Lagadic–Gossmann, and Marie–Therese Dimanche–Boitrel.
24. Hyperpolarization of Plasma Membrane of Tumor Cells Sensitive to Antiapoptotic Effects of Magnetic Fields: S. Nuccitelli, C. Cerella, S. Cordisco, M.C. Albertini, A. Accorsi, M. De Nicola, M. D’alessio, F. Radogna, A. Magrini, A. Bergamaschi, and L. Ghibelli.
25. Melatonin as an Apoptosis Antagonist: Flavia Radogna, Laura Paternoster, Maria Cristina Albertini, Augusto Accorsi, Claudia Cerella, Maria D’alessio, Milena De Nicola, Silvia Nuccitelli, Andrea Magrini, Antonio Bergamaschi, and Lina Ghibelli.
26. Prevention of p53